The role of transition metals in the pathogenesis of Parkinson's disease
- 1 December 1995
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 134, 69-78
- https://doi.org/10.1016/0022-510x(95)00210-s
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Does iron play a role in Parkinson's disease?Hyperfine Interactions, 1994
- Progressive Changes in Striatal Dopaminergic Markers, Nigral Volume, and Rotational Behavior Following Iron Infusion into the Rat Substantia NigraExperimental Neurology, 1994
- Ferrous‐Citrate Complex and Nigral Degeneration: Evidence for Free‐radical Formation and Lipid PeroxidationaAnnals of the New York Academy of Sciences, 1994
- The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controlsNeurochemical Research, 1993
- Purified Human Neuromelanin, Synthetic Dopamine Melanin as a Potential Model Pigment, and the Normal Human Substantia Nigra: Characterization by Electron Paramagnetic Resonance SpectroscopyJournal of Neurochemistry, 1993
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural markerJournal of Comparative Neurology, 1981
- LIPOPROTEIN PIGMENTS—THEIR RELATIONSHIP TO AGEING IN THE HUMAN NERVOUS SYSTEMBrain, 1974
- ParkinsonismNeurology, 1967